CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.31%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.17B
AUM Growth
+$808M
(+19%)
Cap. Flow
+$413M
Cap. Flow
% of AUM
8%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
725
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$45.5M |
| 2 |
Gilead Sciences
GILD
|
+$39.4M |
| 3 |
GE Aerospace
GE
|
+$36.8M |
| 4 |
Motorola Solutions
MSI
|
+$26M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$24.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$55.4M |
| 2 |
Amgen
AMGN
|
+$30M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$23.3M |
| 4 |
Canadian National Railway
CNI
|
+$21.7M |
| 5 |
Becton Dickinson
BDX
|
+$18.5M |
Sector Composition
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.92% |
| 4 | Communication Services | 9.3% |
| 5 | Consumer Staples | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Edwards Lifesciences
EW
$46.9B
| $3.39M | 0.07% |
108,222
+40,734
| +60% | +$1.28M |
|
327
Ambarella
AMBA
$3.61B
| $3.39M | 0.07% |
61,962
+38,647
| +166% | +$2.11M |
|
328
CDW
CDW
$22B
| $3.38M | 0.07% |
+58,609
| New | +$3.38M |
|
329
Lumen
LUMN
$5.78B
| $3.37M | 0.07% |
143,105
+7,406
| +5% | +$175K |
|
330
CytomX Therapeutics
CTMX
$345M
| $3.37M | 0.07% |
195,000
+40,000
| +26% | +$691K |
|
|
SPLK
331
DELISTED
Splunk Inc
SPLK
| $3.33M | 0.06% |
53,467
+30,166
| +129% | +$1.88M |
|
332
Ovintiv
OVV
$10.6B
| $3.32M | 0.06% |
56,902
+10,898
| +24% | +$637K |
|
333
Vanda Pharmaceuticals
VNDA
$266M
| $3.32M | 0.06% |
237,000
| – | – |
|
|
FDC
334
DELISTED
First Data Corporation
FDC
| $3.32M | 0.06% |
+213,837
| New | +$3.32M |
|
|
IMMU
335
DELISTED
Immunomedics Inc
IMMU
| $3.3M | 0.06% |
+510,000
| New | +$3.3M |
|
|
EPZM
336
DELISTED
Epizyme, Inc
EPZM
| $3.29M | 0.06% |
192,000
-17,000
| -8% | -$292K |
|
337
Bank of New York Mellon
BK
$73.9B
| $3.29M | 0.06% |
69,593
+11,030
| +19% | +$521K |
|
|
HOLI
338
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $3.27M | 0.06% |
192,819
+118,982
| +161% | +$2.01M |
|
339
Aflac
AFL
$56.9B
| $3.23M | 0.06% |
89,262
+7,788
| +10% | +$282K |
|
340
Veeco
VECO
$1.49B
| $3.23M | 0.06% |
108,283
+56,486
| +109% | +$1.69M |
|
341
Xencor
XNCR
$600M
| $3.23M | 0.06% |
135,000
+60,000
| +80% | +$1.44M |
|
|
PTLA
342
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.16M | 0.06% |
80,500
-4,500
| -5% | -$176K |
|
343
APA Corp
APA
$7.75B
| $3.15M | 0.06% |
61,233
-102,991
| -63% | -$5.29M |
|
|
ITCI
344
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.12M | 0.06% |
192,000
+75,000
| +64% | +$1.22M |
|
345
Southern Company
SO
$100B
| $3.11M | 0.06% |
62,420
+11,964
| +24% | +$596K |
|
|
EVHC
346
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.1M | 0.06% |
+50,550
| New | +$3.1M |
|
347
Charles Schwab
SCHW
$170B
| $3.1M | 0.06% |
75,901
+17,179
| +29% | +$701K |
|
348
Truist Financial
TFC
$58.4B
| $3.09M | 0.06% |
69,196
+10,436
| +18% | +$466K |
|
349
American Electric Power
AEP
$57.5B
| $3.08M | 0.06% |
45,854
+6,717
| +17% | +$451K |
|
350
Dominion Energy
D
$49.5B
| $3.07M | 0.06% |
39,554
+8,053
| +26% | +$625K |
|